Assessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model Approach

Using a multi-model ensemble approach, this study projects that for the 2025-26 US COVID-19 season, a broad vaccination campaign targeting all eligible individuals and initiated earlier in the year (late June) would avert the most hospitalizations compared to a high-risk-only or later (mid-August) rollout.

The Gist

Imagine the United States is a giant ship sailing through a stormy sea. The storm is SARS-CoV-2 (the virus that causes COVID-19), and even six years after it first appeared, it's still tossing waves of illness against the ship, threatening to fill the lifeboats (hospitals) with sick passengers.

The crew (scientists and public health experts) gathered at a "weather station" called the US Scenario Modeling Hub to try and predict the next six months of the voyage (April 2025 to April 2026). They wanted to answer a crucial question: How should we use our new "storm shields" (vaccines) to keep the ship safe?

They didn't just guess; they used eight different teams of expert forecasters to run a simulation, like running a video game eight times with slightly different rules to see what happens. They tested five different strategies:

1. The "No Shield" Scenario: What if we didn't use any vaccines at all? (This was the baseline to measure against).
2. The "Classic" Plan: Give vaccines only to the most vulnerable passengers (like the elderly or those with health issues) starting in mid-August (just before the usual winter storm season).
3. The "Broad" Plan: Give vaccines to everyone who is eligible, still starting in mid-August.
4. The "Early & Broad" Plan: Give vaccines to everyone starting earlier, in late June, to get ahead of the storm.

What Did the Crystal Ball Show?

The forecasters found that using the vaccines makes a huge difference, like patching holes in the ship before the waves get too big:

• The "Classic" Plan: If they only vaccinated the high-risk group starting in August, they estimated they could save the ship from 90,000 people needing hospitalization. That's like keeping a massive crowd of people off the lifeboats.
• The "Broad" Plan: If they expanded the shield to cover everyone eligible, they saved an extra 26,000 people. It's like realizing that protecting the whole deck is better than just protecting the captain's quarters.
• The "Early & Broad" Plan: If they started giving those broad shields even earlier (in June), they might save another 15,000 people. Think of this as putting up the storm shutters before the first cloud even appears, rather than waiting until the rain starts.

The Big Picture

The experts also predicted that the storm isn't just a one-time event; they saw two waves coming—one in the summer and a bigger one in the winter.

The Takeaway:
The study concludes that if we want to keep our hospital "lifeboats" from overflowing in the 2025-26 season, we have a clear strategy: Don't wait. We should offer vaccines to everyone who can take them, and we should start handing them out as early as possible. While the virus is still a powerful storm, these "shields" are our best tool to keep the ship steady and the passengers safe.

Technical Summary

1. Problem Statement

Six years after the emergence of SARS-CoV-2, the virus continues to impose a significant public health burden. Despite existing population immunity from prior infection and vaccination, uncertainty remains regarding:

• The specific impact of future vaccination campaigns.
• The optimal timing for vaccine rollout, particularly given the variability in outbreak seasons (summer vs. winter).
• The trade-offs between targeting high-risk populations versus broader eligibility groups.

The study aims to quantify the potential reduction in hospitalizations and deaths under various vaccination strategies to inform public health policy for the 2025–2026 season.

2. Methodology

The study utilized a Multi-Model Ensemble Approach coordinated by the US Scenario Modeling Hub (SMH).

• Data Source & Scope: The 19th round of ensemble projections involved eight independent modeling teams.
• Geographic & Temporal Scope: Projections covered all US states and the national level for the period from April 2025 to April 2026.
• Scenario Design: The models evaluated five distinct scenarios:
  1. Counterfactual: No vaccination campaign.
  2. High-Risk Only / Classic Timing: Vaccination recommended only for high-risk individuals, starting mid-August.
  3. All-Eligible / Classic Timing: Vaccination recommended for all eligible age groups, starting mid-August.
  4. High-Risk Only / Early Timing: Vaccination recommended only for high-risk individuals, starting late June.
  5. All-Eligible / Early Timing: Vaccination recommended for all eligible age groups, starting late June.
• Analysis: The teams projected trajectories for hospitalizations and deaths, comparing the intervention scenarios against the no-vaccination counterfactual to calculate averted outcomes.

3. Key Contributions

• Ensemble Robustness: By aggregating projections from eight diverse modeling teams, the study mitigates the biases inherent in single-model approaches, providing a more robust estimate of potential outcomes.
• Granular Scenario Testing: The study uniquely isolates the variables of coverage (high-risk vs. all-eligible) and timing (mid-August vs. late June) to determine their independent and combined effects.
• Forward-Looking Projections: It provides critical data for the 2025–2026 season, a period where population immunity dynamics and viral evolution are expected to shift significantly.

4. Key Results

The ensemble projections estimated the following impacts compared to a scenario with no vaccination:

• High-Risk / Classic Timing: Projected to avert 90,000 hospitalizations (95% Prediction Interval [PI]: 53,000–126,000).
• Impact of Expanded Coverage: Expanding eligibility to all age groups (while maintaining classic timing) averted an additional 26,000 hospitalizations (95% PI: 14,000–39,000).
• Impact of Earlier Timing: Shifting the start date to late June, when combined with the all-eligible strategy, was projected to further reduce national hospitalizations by 15,000 (95% PI: -3,000 to 33,000).
  • Note: The prediction interval for the timing benefit includes zero, suggesting some model uncertainty regarding the magnitude of the early start benefit, though the point estimate indicates a positive trend.
• Seasonal Dynamics: The majority of modeling teams projected the occurrence of both summer and winter waves of infection during the study period.

5. Significance and Implications

• Substantial Disease Burden: The study confirms that COVID-19 is expected to cause significant hospitalizations and deaths in the US during the 2025–26 season, necessitating continued vigilance.
• Policy Recommendation for Broad Coverage: The results strongly support a broad, all-eligible vaccination recommendation over a strategy limited to high-risk groups, as it yields a substantial additional reduction in hospitalizations.
• Value of Early Intervention: While the statistical certainty varies, the data suggests that earlier vaccination campaigns (starting in late June rather than mid-August) likely provide additional public health benefits by mitigating the onset of summer and winter waves.
• Funding Context: The research was supported by major US federal agencies, including the CDC, NIH, and NSF, underscoring its role in national pandemic preparedness planning.

In conclusion, the study provides quantitative evidence that a combination of broad eligibility and earlier rollout timing offers the most effective strategy for minimizing the 2025–2026 COVID-19 burden in the United States.